Rapid improvement in post-stroke pain and additional clinical improvements documented following the INR’s patented anti-TNF treatment, 17 years after stroke.
Chronic neurological dysfunction produced by stroke and traumatic brain injury has long been thought to be irreversible. A new scientific discovery by the INR, as documented in the video above, now promises to change current thinking about the potential for recovery of function, even years after the acute event.
Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional treatment doses may be necessary to maintain the clinical response. Treatment for this indication is off-label. Please see the Terms of Use. The method of treatment utilized is a patented invention of the INR. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. patents 6419944, 6537549, 6982089, 7214658, 76929311, 8119127, 8236306, 8349323 and 8900583 all assigned to TACT IP, LLC; and Australian patent 758523.